New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
07:21 EDTICPTIntercept price target raised to $493 from $449 at Wedbush
Wedbush raised its price target for Intercept Pharmaceuticals shares to $493 saying a new Phase 2 clinical study for OCA in alcoholic hepatitis increases the company's acquisition value. The firm reiterates an Outperform rating on the stock.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:05 EDTICPTOrbiMed reports 7% stake in Intercept
Subscribe for More Information
August 26, 2014
07:46 EDTICPTIntercept Pharmaceuticals volatility at low end of historic range
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use